Chemotherapy by unknown
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QT1 - INHIBITION OF THE OUABAIN-INSENSITIVE NA+-
ATPASE ACTIVITY FROM EPIMASTIGOTES OF
TRYPANOSOMA CRUZI BY MILTEFOSINE
Saraiva, V.B. (1), Gomes-Quintana, E. (2), Rocha, T. (1), Previato, J.O. (1),
Mendonça-Previato, L. (1), Caruso-Neves, C. (2) and Heise, N. (1)
(1) Laboratório de Glicobiologia e (2) Laboratório de Bioquímica Renal, IBCCF-
UFRJ.
Miltefosine, initially developed as an anti-tumor agent, is the newest drug
for the treatment of visceral leishmaniasis. Several laboratories have shown that
this ether-lipid analogue is also toxic against different forms of T. cruzi, but its
mechanism(s) of action is(are) still unclear. In leukemic cells, Miltefosine seems
to interfere with cellular signal transduction pathways by inhibition of protein
kinase C (PKC) and Na+, K+-ATPase. In order to verify if Miltefosine is able to
act in a similar way on T. cruzi, we initially tested its effects against on the
ouabain-insensitive and furosemide-sensitive Na+-ATPase activities of the
parasites (1).
The Na+-ATPase activitiy was measured as described previously (1-2) using
an enriched plasma membrane fraction from epimastigotes obtained after sub-
cellular fractionation by differential centrifugation in sucrose-containing buffer.
The addition of increasing amounts of Miltefosine (0,003-0,3 mg/mL) resulted
in a dose-dependent inhibition of the Na+-ATPase activity. In a second stage,
the inhibition of the Na+-ATPase by Miltefosine was confirmed by performing
activity measurements in the presence of increasing amounts of NaCl, containing
or not 0,015mg/mL of Miltefosine. As expected, there was a Na+-dependent
increase of the Na+-ATPase activity, with a K0.5 and Vmax of 13.7±1.9 mM Na+
and 11.4±0.5 nmol Pi x mg-1 x min1, respectively. In the presence of Miltefosine
there was a change in the kinetic parameters, with the K0.5 for Na+ raising to
28.5±5.3 mM and the V
max
 dropping to 7.6±0.5 nmol Pi x mg-1 x min1. When the
membrane fractions were pre-incubated with Miltefosine (0,015 mg/mL) and
diluted to a condition containing four times less drug before performing the
assay, no inhibition was observed when compared to controls. Taken together,
the results suggest that Miltefosine act as a reversible inhibitor of the T. cruzi
Na+-ATPase.
Supported by: CNPq, FAPERJ, TWAS and IFS.
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QT2 - ATIVIDADE ANTIPARASITÁRIA DA HEMOLINFA DE
DUAS ESPÉCIES NATIVAS DE MOLUSCOS BIVALVES
Löfgren, S.E.1; Steindel, M.2; Barracco, M.A.1
1 Depto de Biologia Celular, Embriologia e Genética - CCB -UFSC -
Florianópolis, SC. 2 Depto de Microbiologia e Parasitologia – CCB – UFSC -
Florianópolis, SC
Peptídios ou proteínas antimicrobianas (PAM) são componentes do sistema
imune inato, presentes na maioria dos seres vivos, que podem apresentar uma
atividade microbicida potente contra um amplo espectro de microrganismos.
Entretanto, dos PAM conhecidos atualmente, muito poucos têm sido avaliados
quanto a sua atividade antiparasitária contra protozoários. Neste trabalho foi
investigada a atividade antiparasitária da hemolinfa de duas espécies nativas de
moluscos, o mexilhão Perna perna e a ostra do mangue Crassostrea rhizophorae,
contra formas promastigotas de Leishmania (V.) braziliensis e formas epimastigotas
de Trypanosoma cruzi. Foram utilizadas as duas frações hemolinfáticas: plasma
(PL) e sobrenadante de lisado de hemócitos (SLH). Culturas de ambos parasitas
(107 células/mL, concentração final) foram incubadas em microplacas de 96
poços, com um volume igual das frações hemolinfáticas de ambos bivalves em
diferentes concentrações, por um período de até 48 h. A atividade antiparasitária
foi determinada pelo ensaio colorimétrico do sal de tetrazolium (MTT). A inibição
do crescimento dos parasitas foi avaliada a partir da concentração protéica mínima
das frações hemolinfáticas capaz de inibir em 50% o crescimento normal do
parasita (EC50). Foi detectada uma atividade inibitória contra ambos parasitas,
no PL tanto de C. rhizophorae (EC50 = 300mg/mL para L. (V.) braziliensis e
EC50 = 150mg/mL para T. cruzi) como de P. perna (EC50 = 240 mg/mL para L.
(V.) braziliensis e EC50 = 600 mg/mL para T. cruzi), após um período de incubação
de 24h. O SLH de C. rhizophorae não apresentou atividade antiparasitária até
48 h, enquanto o de P. perna mostrou-se inibitório após 48h (EC50 = 45 mg/mL
para L. (V.) braziliensis e EC50 = 150 mg/mL para T. cruzi). Controles adequados
mostraram que a concentração salina da hemolinfa não interfere no crescimento
de ambos protozoários. Os resultados obtidos apontam para ocorrência de uma
atividade inibitória da hemolinfa de ambos bivalves sobre L. (V.) braziliensis e
T. cruzi. Análises ulteriores são necessárias para melhor avaliar esta atividade e
o interesse de se partir para uma purificação dos eventuais fatores antiparasitários.
QT3 - ATIVIDADE ANTIPARASITÁRIA DE PEPTÍDIOS DA
HEMOLINFA DO CAMARÃO PENEÍDEO LITOPENAEUS
VANNAMEI
Löfgren, S. E.1; Steindel, M.2; Bachère, E.3; Barracco, M. A.1*
1
 Depto de Biologia celular, Embriologia e Genética – CCB – UFSC,
Florianópolis, SC, Brasil. 2 Depto de Microbiologia e Parasitologia - CCB –
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Peptídios antimicrobianos (PAM) são moléculas integrantes do sistema
imune inato de vertebrados e de invertebrados que funcionam como antibióticos
naturais e que apresentam geralmente uma atividade microbicida rápida e potente
contra um amplo espectro de microrganismos. Dos PAM conhecidos atualmente,
muito poucos têm sido avaliados quanto a sua atividade antiparasitária contra
protozoários, sendo principalmente caracterizados em relação a sua atividade
antibacteriana e antifúngica. Neste trabalho foi investigada a atividade
antiparasitária do peptídio recombinante peneidina (Pen 3a), expresso em
leveduras, e do fragmento C-terminal da hemocianina (C-ter), ambos isolados e
caracterizados da hemolinfa de L. vannamei, espécie altamente cultivada em
países da América Latina. A Pen 3a caracteriza-se principalmente pela sua
atividade anti-bactérias Gram positivas, enquanto o C-ter pela sua atividade
antifúngica. Em nossos ensaios, utilizamos formas promastigotas e epimastigotas
de Leishmania (V.) braziliensis e Trypanosoma cruzi, respectivamente. Culturas
de ambos parasitas (107 células/mL, concentração final) foram incubadas em
microplacas de 96 poços com diluições seriadas (concentraçao inicial de 100
mM) de ambos peptídios. Os ensaios foram realizados em meio de cultura
Schneider (L. (V.) braziliensis) ou TC-100 (T. cruzi) com suplementação de
glicose (1%) e as placas foram incubadas por 20 h para avaliação do efeito
inibitório sobre o crescimento (proliferação) dos parasitas. No caso da Pen 3a,
foi também testada uma incubação de 5 h para verificar um possível efeito lítico/
citotóxico. A atividade antiparasitária foi determinada pelo ensaio colorimétrico
do sal de tetrazolium (MTT), quantificando a viabilidade celular das culturas de
ambos parasitas. Foi detectada uma pequena atividade inibitória da Pen 3a e do
C-ter contra ambos protozoários. O efeito mais significativo foi o da Pen 3a
contra T. cruzi, causando uma redução de 30% na viabilidade dos parasitas a
uma concentração de 12,5 mM, após 20h de incubação. Após esse mesmo
período, a incubação com o C-Ter causou uma pequena redução (10%) na
viabilidade celular a uma concentração de 100 mM contra ambos parasitas. A
incubação por um período de 5 h com Pen 3a (ate 80 mM) não causou nenhum
efeito sobre T. cruzi e uma pequena inibição sobre L. (V.) braziliensis (redução
de 20% na viabilidade celular). Os resultados obtidos até o momento apontam
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para a ocorrência de uma fraca atividade antiparasitária dos peptídeos, sendo
um pouco mais relevante a ação da Pen 3a sobre o T. cruzi. Um maior número de
análises é ainda necessário para possibilitar conclusões mais definitivas.
Financiamento: CEE – Immunaqua ICA4-CT-2001-10023
QT4 - ACTIVITY OF OLEANOLIC ACID AGAINST
LEISHMANIA (L.) MAJOR IN VITRO
DELORENZI, JC1,2; COSTA, DA2; Castilho RO3; Kaplan, MAC4 & GATTASS,
CR2
1Laboratório de Imunofarmacologia Experimental, Faculdade de Ciências
Biológicas e da Saúde, Curso de Farmácia – Campus V (Itaperuna), Universidade
Iguaçu; 3Universidade Católica Dom Bosco (UCDB), MS; Instituto de Biofísica
Carlos Chagas Filho e 4Núcleo de Pesquisas em Produtos Naturais, UFRJ, Brasil;
Leishmaniasis is a major world wide health problem, with around 3 million
people infected and 600 thousand new cases appearing each year. In Brazil, 30
thousand new cases appear annually only in the Northeast region. Since 30’s
pentavalent antimonals are the first line treatment for leishmaniasis.
Disadvantages such as costs, long-term treatment, side effects and low efficacy
against many strains are reported. Although great efforts had done along the last
century to develop new drugs for leishmaniasis treatment, a drug with high
efficacy and low side effects is still need. Furthermore, a drug for oral
administration is desirable. All this, prompted the search for new
chemotherapeutic agents. Among all strategies used to develop new agents against
leishmaniasis, the research of natural products produced good results.
This work investigated the leishmanicidal activity of oleanolic acid (OA), a
triterpene isolated from fruits of Licania tomentosa Benth, a Brasilian plant.
Oleanolic acid was dissolved in DMSO then diluted in media for use. The
leishmanicidal activity of oleanolic acid was investigated against the two
evolutive forms of Leishmania (L.) major (LV39 strain). Promastigotes of L.
(L.) major (106/well) was incubated in 96 well plate with different drug
concentrations (1 to 50 µg/ml) or with DMSO at the same concentratrions carried
by the drug. After 24 and 48hr, parasite survival was determined by MTT, a
technique based on mitochondrial activity. Treatment with 20 µg/ml OA for
24h or 48h inhibited parasite survival in 88% and 95%, respectively. The activity
on amastigotes was tested on L. (L.) major infected mouse peritoneal
macrophages (10:1 parasite:macrophage ratio) by counting the number of
intracellular parasites. Infected macrophages were treated with different drug
concentrations and 24h later infection was evaluated by optical microcopy.
Treatment with 20 µg/ml of OA resulted in 88% inhibition of parasite infection.
The viability of mouse peritoneal macrophages was not affected by a 24h treatment
with 20 µg/ml or lower doses of OA.
The results presented herein, showing that oleanolic acid is able to kill the
two evolutive forms of L. (L.) major without affecting macrophages viability,
points to this triterpene as a strong candidate for the development of a new
leishmanicial drug.
Supported by: CNPq, FAPERJ.
QT5 - “IN VITRO” AND “IN VIVO” TRYPANOCIDAL
POTENTIAL OF VERNONIA SPECIES (ASTERACEAE)
Osakabe, A.L.; Albuquerque, S..
Laboratório de Parasitologia - FCFRP - USP
The protozoan parasite Trypanosoma cruzi is responsible to determinate
Chagas’ disease, a serious debilitating disease that affects millions of people in
Latin America. Tripomastigotes are capable of invading and replicating in
different types of cells causing a chronic and multifocal disease. Benznidazole
is only drug employed to treatment of this infection in Brazil but its acts are
dubious still. The efficacy depends on strain of T. cruzi. In the present work we
evaluated the trypanocidal potential of different plant extracts of the genus
Vernonia “in vitro” and “in vivo” assays, against two strains of T. cruzi (Y and
Bolivia). The “in vitro” assay was carried out using blood with 105
trypomastigotes forms/mL and it was added in extract solutions (V. cognata, V.
fruticulosa, V. lacunosa and V. rupestris) prepared in dimethyl sulfoxide 5%
(DMSO): saline (1:20) to provide different concentrations 2.000, 1.000 and 500
mg/mL. The bioassays were performed in triplicate on microtitle plate (96 wells);
negative and positive controls containing either DMSO or gentian violet
respectively were run in parallel. The plate was incubated at 4oC during 24
hours and the number of parasites determined according to Brener method. The
better results found by the “in vitro” assay were evaluated “in vivo” assay. The
better crude extract analyzed were ethyl acetate and hexanic of Vernonia
fruticulosa and V. rupestris, extracted of leaves. Male, healthy and young mice
(BALB/C) were inoculated intraperitoneally with 4 x 103 tripomastigotes forms
and 48 hours after that the extracts were administrated. The extracts were prepared
in and administered by oral way at 8 mg/kg/day for 20 days. Positive control
(benznidazole) and negative control (DMSO 5%) groups were done. The count
of parasites was performed according to Brener method. We observed that the
strains showed different behaviors. “In vitro” assay there were a difference
between Y and Bolivia strains and V. fruticulosa showed the lowest value of IC50
by the two strains. To “in vivo” assay with extract of V. fruticulosa in Y strain
reduced the parasitemia but the mice had precocious death while compared with
positive control. Bolivia strain showed a high parasitemia curve and survival
period even the controls the same occurred with V. rupestris to Y strain. To
Bolivia strain this crude extract showed lower parasitemia and reduced the
survival of animals if compared with positive and negative controls. We concluded
that the genus Vernonia is not capable to treat the parasite infection by the Y and
Bolivia strains. To prevent the Chagas’s disease V. fruticulosa need more studies
to know that one fraction can be capable to it.
Supported: CNPq
QT6 - PIPERACEAE AND SOLANACEAE SPECIES AGAINST
LEISHMANIA (L.) AMAZONENSIS
Pacienza-Lima, W.1; Souza, E.V.1; Lafetá, R.C.A.2; Velozo, L.S.M.2; Kaplan,
M.A.C.2; Sampaio-Santos, M.I.3 & Torres-Santos, E.C.1
1 – Curso de Farmácia e Bioquímica, Universidade Severino Sombra; 2 – NPPN,
Universidade Federal do Rio de Janeiro; 3 – Faculdade de Farmácia, Universidade
Federal do Rio de Janeiro.
The number of new cases of leishmaniasis has increased in the last years in
Brazil. Vassouras is a small town situated in an endemic region in the interior of
the Rio de Janeiro state, where there is a high number of infected people in rural
areas. The present work is part of a project that aims to research the therapeutical
potential of the Rio de Janeiro state flora. Plant extracts of several polarities
from different organs of the families Piperaceae, Solanaceae, Cucurbitaceae and
Rubiaceae have been evaluated. Promastigotes of Leishmania (L.) amazonensis
were cultivated with extracts in several concentrations for 96h at 26oC. To evaluate
the antiamastigote activity, murine peritoneal macrophages were infected with
L. (L.) amazonensis and treated with extracts for 48h at 37oC. Leaf extracts of
Aureliana angustifolia (Solanaceae), Piper mallacophylum and Peperomia
scandens (Piperaceae) at 100 mg/ml inhibited in more than 90% the growth of
both forms of the parasite. The solvents used in the extration have also influenced
the result, being the polarity directly proportional to the leishmanicidal activity.
The microscopical analysis of the macrophages treated with extracts indicated
variable degree of cytotoxicity in concentrations higher than 100mg/ml. These
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results indicate that the phytochemical study guided by leishmanicidal assays
of the active plants can result in the isolation and identification of new
phytomedicines for leishmaniasis treatment. FUSVE.
QT7 - ANTI-LEISHMANIAL ACTIVITY FROM TITHONIA
DIVERSIFOLIA LEAVES EXTRACT
Toledo JS*, Ambrosio SR**, Cerri D*, da Costa FB** and Cruz AK*.
*Departamento de Biologia Celular, Molecular e Bioagentes Patogênicos da
Faculadade de Medicina de Ribeirão Preto-USP.
**Departamento de Ciências Farmacêuticas da Faculdade de Ciências
Farmacêuticas de Ribeirão Preto-USP.
Leishmania is a protozoan parasite responsible for a group of diseases whose
symptoms range from mild cutaneous lesions to fatal visceral involvement. The
unavailability of appropriate drugs to treat the disease is a result of a combination
of factors including the lack of ongoing “research and development” into
neglected diseases, such as leishmaniasis for which there is virtually no market.
With that in mind, we decided to search for anti-protozoan activity in crude
extract from the leaves of a plant, Tithonia diversifolia, known in Brazil as
“margaridão”. Dicloromethane leaves extract (DLE) was prepared and tested
for its leishmanicidal activity against Leishmania (L.) major axenic
promastigotes. The DLE was shown to be cytotoxic, acting on promastigotes
and the IC50 value lies between 1,5-2 mg/mL. Furthermore, scanning electron
microscopy experiments demonstrate drastic morphological alterations in L. (L.)
major promastigotes. We are currently testing the DLE effect on mammalian
cells and on parasites’ invasion kinetics.
Supported by FAPESP.
QT8 - PRELIMINARY ANALYSIS OF THE TRYPANOCIDAL
AND LEISHMANICIDAL PROPERTIES OF XANTHONES
DERIVATIVES.
ÉCKELI, I.W.1; MACHADO, D.S.B.1; SIMON, R.F.1; PERSUHN, D.C.1;
PINHEIRO, T.R.2; YUNES, R.A.2; CALIXTO, J.B.2; STEINDEL, M.2;
GRISARD, E.C.2; SANTOS, A.R.S.2 & EGER-MANGRICH, I.1
1- Universidade do Vale do Itajaí, Centro de Ciências da Saúde, Rua Uruguai,
458, CEP 88 302-202 - Itajaí-Santa Catarina. E-mail: iriane@ccs.univali.br; 2-
Universidade Federal de Santa Catarina, Florianópolis-SC.
Xanthones have a broad spectrum of biological activities including cytotoxic
and anticancer, anti-inflammatory and analgesic, antifungal, antiprotozoal and
antidepressant activity. The present study was designed to determine the in vitro
leishmanicidal and trypanocidal activity of the xanthone (C1) and six substituted
xanthones, including 4-methyl-xanthone (C2), 1-carboxy-xanthone (C3), 2-
carboxy-xanthone (C4), 3-carboxy-xanthone (C5); 4-carboxy-xanthone (C6) and
3-methoxy-xanthone (C7). Epimastigotes forms of Trypanosoma cruzi (Y strain)
and promastigotes of Leishmania (L.) amazonensis (579 strain) were washed twice
in cold PBS and their concentration was adjusted to 5x106 cells/mL in LIT medium.
Different concentrations of each compound (500, 300, 100, 30, 10, 3 and 1mg/
mL) were incubated in the presence of 200?L of the parasites suspension in 96
microwell plates at 26°C for 72 hours. As controls, parasites were incubated in the
absence of any drug and in the presence of benznidazole (50mg/mL) or
amphotericin B (50ng/mL). Three to four experiments were carried out in triplicate
and the number of surviving parasites was determined in Neubauer chambers.
The substituted xanthones showed a concentration-dependent inhibitory effect on
the growth of L. amazonensis promastigotes. Among the seven xanthones tested,
C1, C5 and C10 revealed a major inhibitory effect on the growth of L. (L.)
amazonensis, with IC50 values of 317.6mg/mL, 235.9mg/mL and 180.2mg/mL
and inhibition rates of 87±2%, 90±1% and 85±4%, respectively. Except for C5,
which revealed IC50=319.1mg/mL and 70±8% of growth inhibition, all other
xanthones presented no effect against T. cruzi. Along with xanthone C5, which
has a methyl substituent group in position 4 and revealed both leishmanicidal and
trypanocidal activities, our results also showed promising leishmanicidal activity
in some substituted xanthones.
Suported by UFSC, UNIVALI and CNPq.
QT9 - ANTI-LEISHMANIA (L.) AMAZONENSIS ACTIVITY OF
SUPERCRITICAL CO2+ETHANOL EXTRACTS FROM
TABERNAEMONTANA CATHARINENSIS.
Soares, DC1, Pereira, CG2, Meireles, MAA2 and Saraiva, EMB1.
1Departamento de Imunologia, Instituto de Microbiologia, Universidade Federal
do Rio de Janeiro, Rio de Janeiro; 2LASEFI DEA/FEA, Universidade Estadual
de Campinas, São Paulo.
Leishmaniasis is a worldwide disease still treated with expensive compounds
that present severe side effects, and are frequently ineffective, emphasizing the
importance to search new compounds against this disease. Tabernaemontana
catharinensis is a species belonging to the Apocynaceae family that is rich in
indole alkaloids, used in folk medicine as antimicrobial, anti-inflammatory,
antitumor and analgesic. Coronaridine, an indole alkaloid isolated from T.
catharinensis, exhibited a potent leishmanicidal effect (Delorenzi et al, 1998
and 2002). In this work we used supercritical fluid extraction [SFE] to obtain T.
catharinensis extracts. The easy removal of solvent from the final extract, the
high selectivity and the use of moderate temperatures in the process, are the
most significant advantages of this methodology.
Alkaloids, coronaridine and voacangine, were quantified in both extracts
by gas chromatography [GC-FID]. The leishmanicidal effect of the two extracts,
E2 and E4, was evaluated, as well as, their cytotoxicity to macrophages. Mouse
murine macrophages infected with L. (L.) amazonensis stationary phase
promastigotes for 24 hs were treated with E2 and E4 during 24 hs more. Our
results showed that E2 (10 and 100 µg/ml) inhibited 20 and 80%, respectively,
of amastigotes survival, while E4 (10 and 100 µg/ml) inhibited 26 and 100%,
respectively, of parasite growth. In order to test the safety of this extracts, viability
of mouse macrophages treated with both extracts was checked by Trypan dye
exclusion and XTT assays. Both tests showed that E2 and E4 were not toxic for
macrophages. These results point to the use of this methodology as a possibility
to easily produce compounds to treat leishmaniasis.
Supported by: CNPq, FAPESP.
QT10 - INHIBITION OF TRYPANOSOMA CRUZI GROWTH BY
PTERODON PUBESCENS OILY EXTRACT
Braga, S G., Carvalho, F.C.T, Silva, M.C.C., Coelho, M.G.P, Todeschinini, A.
R.
Departamento de Bioquímica, Instituto de Biologia, Universidade do Estado do
Rio de Janeiro, Boulevard 28 de Setembro 87, 20551-013, Rio de Janeiro,RJ,
Brasil
Trypanosoma cruzi is the etiologic agent of Chagas´ disease, an endemic
disease in Central and South America. Chemotherapy of this disease is still very
unsatisfactory, being based in nitrofurans and nitroimidazoles. These compounds
are inadequate due to frequent toxic side effects and limited efficacy having
little or no activity in the chronic phase of the disease. These facts show us the
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urgency for the development of new drugs more effective and less toxic for
Chagas´ disease. Pterodon pubescens Benth (leguminosae), known as Sucupira
branca is a native tree specie of Brazil and its seeds are used as hydroalcoholic
infusion presenting anti-rheumatic, analgesic, anti-inflammatory and cercaricide
properties. Toxicological studies demonstrated that the P. pubescens seeds
extracts did not present acute or sub-acute toxicity. Geranylgeraniol and related
substances (14,15-epoxygeranylgeraniol and 14,15-dihydro-14,15-
dihydroxygeranylgeraniol) have been associated to the cercaricide activity of
Pterodon pubescens oil. Isoprenoids are involved in cell proliferation and
differentiation, and much work is being done nowadays to study these
compounds, especially farnesol and geranylgeraniol, that are also involved in
post-translational prenylation of proteins, facilitating protein-protein interactions
and membrane-associated protein trafficking. In this work we study the effects
of oleaginous extract of P. pubescens seeds (Ppoe), the hexanic fraction (Hex)
and geranilgeraniol in the growth of T. cruzi epimastigotes from Y strain. Ppoe
was obtained by maceration of Pterodon pubescens seeds in ethanol at room
temperature for 15 days. A hexanic extract (Hex) from Ppoe was obtained by
liquid-liquid extraction. Geranilgeraniol was further obtained from Hex by HPLC
in a C8 column and characterized by GC-MS and NMR. The epimastigotes
were grown in BHI, with 10% SFB, 10mg l-1 hemin and 20mg l-1 folic acid for
25ºC for 7 days in the presence and in the absence of Poep or H2. The EOPp,
Hex and H2 presented a dose-dependent inhibition of epimastigotes growth
with an IC50 of 12.31; 13.64 and 31.84 mg/ml respectively. Studies to the
mechanism of action of the geranilgeraniol in the cellular division of the T.
cruzi are in course in our laboratory.
Acknowledgments: CNPQ, FAPERJ.
QT11 - TRYPANOCIDAL ACTIVITY OF THE GALLIC ACID
DERIVATIVES
Legat-Albino, D.B.1, Pacheco, L.K. 1, Leal, P.C.2, Nunes, R.2, Yunes, R.A.2, Santos,
A.R.S.3, Grisard, E.C.1, Steindel, M.1
1- Departamento de Microbiologia e Parasitologia, 2- Departamento de Química
and 3- Departamento de Fisiologia, Universidade Federal de Santa Catarina
(UFSC), Caixa postal 476, Florianópolis, SC, 88040-900. E-mail:
ccb1mst@ccb.ufsc.br
Gallic acid (3,4,5-trihydroxybenzoic acid) is a phenolic compound
commonly found in plant species as an ester or hydrolyzable tannins, presenting
some important biological activities such as inhibition of tumoral cells
proliferation and anti-parasite activity against Trypanosoma brucei and
Leishmania spp. In this work we have evaluated the “in vitro” trypanocidal
activity of 25 derivatives of the gallic acid which were synthetized by the
Department of Chemistry (UFSC). The assays were performed in triplicate in
96 well microplates by incubating 180mL of each parasite form suspension
with 20mL of the testing compounds in distinct concentrations (100, 50, 10, 5 e
1mM). Assays were performed with Trypanosoma cruzi Y strain culture
epimastigotes and blood trypomastigotes. Epimastigotes harvested in LIT
medium were washed in PBS and had their concentration adjusted to 5x106
parasites/mL. Trypanocidal assays with these forms were carried out for 72h at
27oC using benznidazole (100mM) as positive control. Blood trypomastigotes
obtained from experimentally infected mice had their concentration adjusted to
1x106 parasites/mL and were incubated with each compound concentration for
48h at 4oC using crystal violet as positive control. As negative controls, parasites
were incubated in the absence of any drug and in the presence of DMSO 2%.
The trypanocidal activity was carried out by determining the number of live
parasites in Neubauer chambers for epimastigotes and according to Brener
method (1962) for trypomastigotes. Four out of 25 assayed compounds showed
trypanocidal activity against epimastigotes: eptyl gallate IC50= 4.1 mM (2.8 -
6.1), octyl gallate IC50=33.9 (28.1 - 40.9), dodecyl gallate IC50=2.3 (1.7 - 2.9)
and undecyl gallate IC50=4.24 (3.0 - 5.8). None of these active compounds showed
activity against T. cruzi blood trypomastigotes and no erithrocyte lysis was
observed. The absence of activity against these forms may be attributed to
hydrolysis of the alkyl chain by blood components. Further studies are in progress
in order to modify the active compounds in order to avoid the action of blood
components in the molecule structure.
Supported by CNPq and UFSC.
QT12 - TRYPANOCIDAL ACTIVITY OF EUGENIA
JAMBOLANA LAM.
Gibaldi, D.1,2; Ramos, M.F.S.3,4; Siani, A.C.3; Bozza, M. T.2& Henriques,
M.G.M.O.1
1Departamento de Farmacologia Aplicada, Far-Manguinhos/FIOCRUZ.
2Laboratório de Inflamação e Imunidade, Instituto de Microbiologia -CCS/UFRJ.
3Departamento de Química de Produtos Naturais, Far-Manguinhos/FIOCRUZ.
4Departamento de Medicamentos, Faculdade de Farmácia –CCS/UFRJ.
Chagas‘ disease is an important endemic illness in Latin America, caused
by the protozoan parasite Trypanosoma cruzi. Although transmission has been
reduced, an effective treatment for the infected population is lacking.
Chemotherapy of Chagas disease is limited to the drugs benznidazole and
nifurtimox, which present low efficacy and several side effects. Moreover, the
increased resistance of the parasite to these drugs is one of major problems for
the successful of the treatment. Myrtaceae is a family belonging to the superorder
Myrtiflorae, order Myrtales (sensu Dahlgren, 1982). This family consists of 130
genera and about 3000 species, many of which are used in popular medicine as
diuretic, anti-inflammatory and anti-hipertensive. Eugenia jambolana was
collected at FIOCRUZ campus, Rio de Janeiro State, Brazil. Essential oil of E.
jambolana was extracted and tested in vitro against trypomastigotes forms from
Y strain of T. cruzi, showing a dose depended trypanocidal effects in 24h of
incubation (IC50 0,8mg/ml). When tested on release of trypomastigotes forms
by infected macrophages, and development of amastigotes inside these cells,
the essential oil also demonstrate a dose dependent effect. Expression of NO
and TNF-a production by infected and noninfected macrophages treated with
jambolana essential oil, indicates that the toxicity against the parasite is
independent of cellular activation. These results suggest E. jambolana essential
oils as potentially useful in the Chagas disease therapy.
QT13 - EVALUATION OF THE BIOLOGICAL ACTIVITY IN
VITRO OF PROPOLIS EXTRACT OVER PROMASTIGOTES
AND AMASTIGOTE FORMS OF LEISHMANIA (VIANNIA)
BRAZILIENSIS.
PONTIN, K.,1 BURGOS, V. O1., TOLDO, M.P.A.2., ALBUQUERQUE, S2.
1-University Stadual of Campinas – Institut of Biologia - UNICAMP (Área de
Concentração – Parasitologia). 2-University of São Paulo – USP – Análises
Clínicas, Bromatológicas e Toxicológicas do Departamento de Ciências
Farmacêuticas de Ribeirão Preto.
Leishmaniosis is a parasitic infection caused by a protozoan of Leishmania
gender. It causes a social and economic impact, being considered the second
infection in incidence after malaria. Antimonials are nowadays the first choice
drugs, although display several side effects and parasistic resistance. For these
reasons many other substances are being tested among them propolis, an apitherapic
product that has been used recently with susccessfull results against protozoan. In
this work, it was evaluated the biologic activity of propolis extract through in
vitro assays over the promastigotes and amastigote forms of Leishmania (Viannia)
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braziliensis. The assays were done in triplicate, being used for promastigote forms
the following propolis concentrations: 1, 10, 30, 50, 100, 250, 500, 750 mg/mL,
in axenic media (LIT modificado) with aproximatelly 106 parasites/mL. For
amastigotes forms, concentrations of propolis were 10, 100, 250 mg/mL using a
macrophage culture infected with 1.5x106 parasites/mL. Biological activity was
seen for promastigotes forms, demonstrating a noteworthy leishmanicyd role for
propolis. Although it was not observed any statistical difference concerning to
positive control (Anfotericin B). Any biological activity was noticed for amastigote
forms in none of the used concentrations.
SUPPORTED - CAPES
QT14 - TRYPANOCIDAL ACTIVITY OF DIFFERENT
PROPOLIS SAMPLES FROM BRAZIL
Pereira, PRCSC 1,*, Salomão, K 1, Pereira AS2, Aquino-Neto FR2, Marcucci
MC3, De Castro SL1
1Lab. de Biologia Celular, DUBC, IOC, FIOCRUZ, RJ, Brazil; 2Ladetec, Instituto
de Química, UFRJ, Brazil; 3Núcleo de Pós-graduação, Pesquisa e Extensão,
Universidade Bandeirante de São Paulo, São Paulo, SP, Brazil
*Corresponding author: neco@stmbecker.com.br
Propolis is a resinous substance that honeybees collect from different plant
exudates and is used to block cracks, seal their honeycombs and also to prevent
growth of microorganisms and protect the hive entrance against intruders [1].
Our laboratory is involved for some years on the investigation of propolis activity
against Trypanosoma cruzi [2-4], inserted in a more wide multidisciplinary study,
which aims to perform a systematic analysis about the chemical composition
and biological activity of Brazilian propolis. In temperate zones the main sources
of propolis are different poplar buds and the bioactivity of this bee product has
been associated mainly to flavonoids and phenolic acids and esters. The samples
from tropical zones, such as Brazil with its vast biodiversity, have become a
subject of increasing scientific and economic attention. In Brazilian samples,
several new compounds with microbicidal and cytotoxic activities have been
already identified [5].
In this context we analyzed the chemical composition of 26 ethanolics
extracts from different localization of Brazil by high temperature high resolution
gas chromatography coupled to mass spectrometry [6] and high performance
liquid chromatograpy [4] and assayed their activity against bloodstream
trypomastigotes. To monitor such activity the parameter used was the value of
ED50/24 h that correspond to the concentration of the extract that lysis 50% of
the parasites after 24 h of treatment. The values these the ED50/24 h varied
between 186 e 2200 mg/mL. Multivariate analysis will be applied to correlate
the trypanocidal activity with the chemical composition of each extract.
References:
[1] De Castro (2001) Ann Rev Biol Sci 3:49-83; [2] Higashi & De Castro, (1994)
J. Ethnopharmacol 43:49; [3] De Castro & Higashi (1995) J.
Ethnopharmacol 46:55; [4] Marcucci et al (2001) J. Ethnopharmacol
74:105; [5] Bankova, De Castro, Marcucci (2000) Apidologie 31:3; [6]
Pereira & Aquino Neto (1999) Trends Anal Chem 18:126.
Supported by Fiocruz and CNPq
QT15 - CHEMICAL COMPOSITION AND MICROBICIDAL
ACTIVITY OF EXTRACTS FROM BRAZILIAN AND
BULGARIAN PROPOLIS
Salomão K.1,*, Dantas A.P.1, Borba C.M.2, Campos L.C.3, Machado D.G.4, Aquino
Neto F. R.4 and De Castro S. L.1,*
1Dept. de Ultra-estrutura e Biologia Celular, 2Dept. de Micologia, 3Dept. de
Bacteriologia, IOC, FIOCRUZ, Brazil, 4Ladetec, Instituto de Química, UFRJ,
Brazil. *Corresponding author. E-mail address: salomao@netrio.com.br
The chemical composition of ethanol extracts from a Brazilian (Et-Bra)
and a Bulgarian (Et-Blg) was determined by high temperature high resolution
gas chromatography coupled to mass spectrometry and assayed in vitro against
against T. cruzi, several fungi and bacteria species were determined. Candida
albicans, Sporothrix schenckii and Paracoccidioides brasiliensis were selected
due to their importance as etiologic agents of mycosis in Brazil and Neisseria
meningitidis, Streptococcus pneumoniae and Staphylococcus aureus are three
common inhabitants of the human nasopharynx that has the potential of causing
fatal diseases. The agar cup method was used for analysis of fungicidal activity
and diameters of less than 15 mm were considered as lack of activity. The minimal
bactericidal concentration was determined by means of the broth microdilution
method and corresponds to the lowest concentration of the extract that yields
negatives subcultures.
Et-Blg presents a predominance of flavonoids (42%), aromatic acids and
esters (12%) and fatty acids (7%) (Prytzyk et al. (2003), J. Ethnopharmacol, in
press), while in Et-Bra it was determined only one flavonoid, pinostrobin (1%),
aromatic acids and amyrins. Both extracts showed a similar content of aromatic
acids and derivatives, but different individual compounds were detected.
In assays with bloodstream trypomastigotes the ED50/24 h for Et-Bra were
66.2±3.7, 380.6±54.5 and 452.6±53.9 mg/mL in assays performed in the presence
of 0%, 5% and 100% blood, and the corresponding values for Et-Blg were
143.0±15.0, 187.4±10.4 and 534.9±52.4 mg/mL. Both extracts showed a similar
activity against trypomastigotes and a decrease in activity due to presence of
blood. Et-Blg and Et-Bra showed a strong and similar activity against C. albicans,
S. schenckii and P. brasiliensis Although both extracts present striking differences
in chemical composition they showed similar effect against T. cruzi and fungi,
indicating that other compounds besides flavonoids are responsible for these
microbicidal effects, such as the high content of aromatic acids, and possibly
the presence of amyrins. In the assays with bacteria Et-Blg was more effective,
particularly N. meningitidis and S. pneumoniae. It is possible that the bactericidal
activity is directly associated with flavonoids, since the main difference between
the two extracts is the high level of these bioactive compounds in the Bulgarian
extract.
Due to the complexity and diversity of propolis, correlation between
chemical composition and biological activity is an approach that can lead to the
standardization and categorization of different samples, allowing considerations
for a more ample therapeutic use of this bee product
Supported by CNPq and Fiocruz.
QT16 - THE IMMUNOLOGICAL PROFILE OF T. CRUZI-
INFECTED MICE TREATED WITH PROPOLIS
Dantas, A.P.*, Olivieri, B.P., Salomão, K. & De Castro, S.L.
Lab. de Biologia Celular, DUBC, Instituto Oswaldo Cruz, FIOCRUZ, 21045-
900, Rio de Janeiro, Brazil
*Corresponding author. E-mail address: andreia@uniamerica.br
In vivo models have been employed in studies with propolis, usually by
administration by oral route of ethanolic or aqueous extracts. In murine models
propolis showed a potent activity as anti-inflammatory, hepatoprotective and
tissue regenerative agents, effects associated with its anti-oxidative (1). Our
laboratory is involved on the investigation of the activity of propolis against
Trypanosoma cruzi (2-4). Treatment of infected mice with 50 mg/kg of propolis
led to lower parasitemia in relation to control group, without interfering with
the survival, and also leading to no toxicity effect up to 700 mg/kg.
In this study we determine the immunological profile of 4 groups of mice:
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non-infected non-treated (G1), non-infected treated (G2), infected non-treated (G3)
and infected treated (G4). Propolis (50 mg/kg) was administered daily by gavage
for 7 and 14 days (corresponding to 8 and 15 dpi for the infected groups).
Differential counting of leukocytes was determined after blood staining with
hematoxilin-eosin and spleens (3 animals/day) from each group were collected
and weighted to determine the absolute mass and for flow cytometry analysis
using a panel anti-mouse monoclonal antibodies (5). The distribution of leukocytes
and the main lymphocyte subsets in the spleen of the four groups after 7 days of
treatment (dt) showed that in G3 the number of lymphocytes increased and
neutrophils decreased, in relation to G1 and G2, maintaining this profile at 14 dt.
Comparison of G3 and G4 showed that the cellular immune response, detected at
8 dpi (7 dt) in non treated mice, occurred only later in infected and treated mice
and that such treatment led to a delay in the switching from innate to adaptative
immune response. At 14 dt, despite showing increased spleen mass, the splenocyte
number of G3 was similar to G1, and the frequency of CD8+ cells of G4 was
higher than in G3 in spite of CD4+ cells present no difference between both groups.
Also at 14 dt, the percentage of expression of CD69+, in CD4+ and CD8+ subsets,
in G4 was lower than in G3, indicating that cell activation due to infection was
partially inhibited by propolis treatment.
Based on these results, we suggest that the treatment of mice with propolis
rich in flavonoids (6) seems to modulate the immune response during T. cruzi
infection, leading to a decrease of parasitemia levels and encouraging us to
continue this research of alternative natural products for Chagas disease.
(1) De Castro SL (2001) Ann Rev Biomedical Sci 3:49-83; (2) De Castro SL,
Higashi KO (1995) J Ethnopharmacol 46: 55-58; (3) Bankova VS et al.
(2000) Apidologie 31:3-15; (4) Marcucci MC et al. (2001) J Ethnopharmacol
74: 105-112; (5) Olivieri BP et al. (2002) Antimicrob Agents Chemother
46: 3790-3796; (6) Prytzyk E et al. (2003) J. Ethnopharmacol, in press.
Supported by CNPq and FIOCRUZ.
QT17 - EFFECT OF ATORVASTIN TREATMENT ON
LEISHMANIA (L.) MAJOR INFECTION
Fernanda Oliveira Ferraz, Helton da Costa Santiago, Lucas Augusto VDR Santos,
Leda Quercia Viera, Mauro Martins Teixeira
Departamento de Bioquímica e Imunologia, ICB, UFMG.
Statins, inhibitors of HMG-CoA Reductase, are used to control cholesterol in
humans. It has been shown that they can modulate inflammatory diseases and
interfere with immune response diminishing Th1 and augmenting Th2 responses.
Leishmania (L.) major is a well-studied parasite that induces type 1 immune
response in resistant models (C57BL/6 mice) and type 2 immune response in
susceptible mouse strains (BALB/c mice). In the present study the effect of
atorvastatin (AT) on L. (L.) major infection was investigated. C57BL/6 mice were
treated with atorvastatin (10 mg/Kg/day, per os) beginning at –2 days (ATLm) or
14 days (LmAT) of infection with L. (L.) major (1x106 stationary forms in hind
footpads). Control groups were infected and treated with vehicle (PBS). The
evolution of the lesions was accessed weekly for 10 weeks and no differences
between groups were found. At the end of experiment, the animals were sacrificed
and the parasitism was quantified. The treated groups presented a significant higher
parasitism (more than 2 log fold increase per mg of lesion). The IFN-γ production
at draining lymph node was also accessed by ELISA. Interestingly, only the ATLm
group presented statistically higher IFN-γ levels whereas LmAT presented a
tendency of higher IFN-γ production when compared to the PBS-treated group.
These results may be associated to a higher parasitism presented in ATLm and
LmAT groups. The presented data suggest that long-term treatment with atorvastatin
may alter the resistance to Leishmania infection.
Support: CNPq
QT18 - MESIONIC DERIVATIVES DECREASES THE NITRIC
OXIDE PRODUCTION BY LEISHMANIA (L.) AMAZONENSIS
PROMASTIGOTES
Soares-Bezerra, R.J.1, Echevarria, A.2, Canto-Cavalheiro, M.M.1, Monteiro, F.P.1,
Leon, L.L.1, Genestra, M1
1Department of Immunology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation-
FIOCRUZ, Rio de Janeiro, Brazil. 2Department of Chemistry, UFRRJ, Rio de
Janeiro, Brazil.
Leishmania is a parasitic protozoa (Kinetoplastida: Trypanosomatidae),
which causes different diseases in human including: cutaneous, mucocutaneous
and visceral leishmaniasis (TDR, 1999). In previous work, our group
demonstrated that the nitric oxide (NO) pathway is involved on Leishmania (L.)
amazonensis-macrophage interaction (Genestra et al., 2003a). Besides, NO
production by L. (L.) amazonensis promastigotes and axenic amastigotes already
was measured and a constitutive nitric oxide synthase (cNOS) was purified and
characterized by immunofluorescence and affinity chromatography (Fonseca-
Geigel, 2000; Genestra et al., 2003b). The significance of the occurrence of
NOS in Leishmania is not known at the present, but the data up to now showed
that NOS is prominent in promastigotes containing a high number of metacyclic
forms, suggesting an association with differentiation and infectivity of the
parasite. As a part of our research program of chemotherapy against leishmaniasis,
we assayed the effect of two salts of mesoionic derivatives. The compounds
have an interesting structure feature and presented useful and wide-ranging
biological activities. In these work, parasites (MHOM/BR/77/LTB0016 strain)
were cultured in Schneider’s medium supplemented with 10% of fetal calf serum
and pH 7.2/26oC. The group tests were assayed with 4-phenyl-5-(4’-methoxy or
3’-methoxy cinnamoyl)-1,3,4-thiadiazolium-2-phenylamine chlorides, the most
active compounds against L. (L.) amazonensis (Silva et al., 2002). The IC50 used
was: 4’OCH3=0.17 mmol/L, 3’OCH3=0.04 mmol/L and 0.46 mmol/L for
Pentamidine (reference drug). After 24 hours, the parasites were counted,
centrifuged and the supernatants were used for the measurement of NO
production by the Griess method (Green et al., 1982). The results demonstrated
that the two compounds tested inhibit significantly (about 60 to 70%/ p<0.001)
the NO production by the parasites, while Pentamidine inhibited only about
25%. If cNOS-L. (L.) amazonensis participates in the establishment of infection
within the macrophage and survive in its “adverse” environment, including
resistance to the toxic products from the host inducible NOS biosynthetic
pathway, the data of the active mesionic class on NO pathway suggest it as
possible target within the parasite. Further experiments will be done in order to
evaluate the effect of 1,3,4-thiadiazolium-2-amidine mesoionic on NADPH
consumption by cNOS purified from L. (L.) amazonensis and in NO production
by axenic amastigotes of these parasites.
Supported by PDTIS, PAPES and IOC/FIOCRUZ
QT19 - BIOCHEMICAL, ANTIPROLIFERATIVE AND
ULTRASTRUCTURAL STUDIES WITH BPQ-OH, A SPECIFIC
INHIBITOR OF SQUALENE SYNTHASE, ON PROMASTIGOTE
AND AMASTIGOTE FORMS OF LEISHMANIA (L.)
AMAZONENSIS AND LEISHMANIA (L.) MAJOR
Juliany C.F. Rodrigues1, Julio A. Urbina2, Luis Miguel Ruiz-Perez3, Dolores G.
Pacanowska3, Wanderley de Souza1
1 Laboratório de Ultraestrutura Celular Hertha Meyer, IBCCF, UFRJ, CCS-Bloco
G, Ilha do Fundão, 21949-900, Rio de Janeiro, Brasil. 2 Laboratório de Química
Biológica, Centro de Bioquímica y Biofísica, Instituto Venezolano de
Investigaciones Científicas, Apartado 21987, Caracas 1020A, Venezuela. 3
Instituto de Parasitologia “López-Neyra”, Consejo Superior de Investigaciones
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Científicas, Calle Ventanilla, 11, Granada, 18001, España. email to
correspondence: julycola@biof.ufrj.br
Parasites of the genus Leishmania are responsible for leishmaniasis, which
affect million of people around the world. Squalene synthase (SQS) is an
important enzyme that catalyzes the first committed step in the sterol biosynthesis.
Some SQS inhibitors have been studied in mammalian cells with the objective
of developing new drugs for the treatment of high cholesterol rates. Leishmania
is a parasite that require an amount of endogenous sterols for growth and viability
and SQS is an essential enzyme for the ergosterol biosynthesis (Urbina et al.,
Mol. Biochem. Parasitol., 125, 35-45, 2002). In this work we decided to
investigate the effect of BPQ-OH, a specific inhibitor of SQS, on promastigote
and amastigote forms of Leishmania (L.) amazonensis and Leishmania (L.) major.
The IC50 for the promastigote forms of L. (L.) amazonensis was 1.03mM. L. (L.)
major was more resistant, presenting an IC50 of 9mM. Total growth arrest and
cell lysis was observed both species incubated with 10mM of BPQ. Intracellular
amastigote forms of L. (L.) amazonensis were 8-fold more sensible than
promastigote presenting an IC50 of 0.106mM. The presence of BPQ-OH in the
culture of both species led to an increase in the expression of the SQS enzyme
when compared with the control without treatment. Densitometry results of the
Western-Blot showed that L. (L.) major presented an increase in the expression
when compared with L. (L.) amazonensis. This result indicates that the
overexpression of SQS in the presence of BPQ-OH is probably related with the
resistance presented by L. (L.) major. Ultrastructural analysis of the treated
parasites revealed intense alterations in the morphology of L. (L.) amazonensis.
The main ultrastructural change was observed in the plasma membrane, that
presented an intense rupture and formation of elaborated structures. Alterations
in the mitochondrion-kinetoplast complex was observed, as intense mitochondrial
swelling, rupture of their membranes and an abnormal compaction of the
kinetoplast. Other alterations include the appearance of multivesicular bodies,
myelin-like figures, some changes in the flagellar membrane and the presence
of parasites with two or more nuclei and kinetoplast. We conclude that BPQ-OH
is a potent inhibitor of the SQS of L. (L.) amazonensis and L. (L.) major, showing
a good IC50, and that SQS is an important enzyme to the control of the ergosterol
biosynthesis in members of the Trypanosomatidae family.
Financial support: CAPES, CNPq, PRONEX, Faperj and European Commission.
QT20 - PIPERINE AND ITS DERIVATES: POSSIBLE
MECHANISMS OF ACTION AGAINST
TRYPANOSOMA CRUZI. A COMPARATIVE STUDY
INVOLVING CHEMICAL STRUCTURE AND BIOLOGICAL
ACTIVITY.
Freire de Lima, L1, Ribeiro, TS2, Romeiro, A1, Rocha, G M3, Brandão, B3,
Mendonça-Previato,. L1, Previato, JO1, Carvalho TM.U3, Lima, MEF2 and Heise,
N1
1
 UFRJ - Instituto de Biofísica Carlos Chagas Filho - Laboratório de
Glicobiologia; 2 UFRuralRJ - Instituto de Ciências Exatas - Departamento de
Química; 3 UFRJ - Instituto de Biofísica Carlos Chagas Filho - Laboratório de
Ultraestrutura Celular Herta Mayer
Piperine is a natural alkaloid isolated from Piper nigrum and has a wide
range of biological activities such as inhibitor of hepatic metabolism and
antiinflamatory, analgesic, larvicidal and leishmanicidal effects. Ten (10)
derivates have been prepared from the natural product through simple chemical
modifications and their toxic effects against T. cruzi were evaluated. The results
allowed us to get information about the importance of the amide function as
well as the length and saturation degree of the central carbon chain for the
biological activity. The results assessed in our laboratory with epimastigotes
and amastigotes forms have demonstrated the promising activity of the natural
product, when compared with its derivatives. The toxic effect of piperine and its
derivates on macrophages was evidenced through the phagocytic and trypan
blue exclusion test, showing the selectivity of the observed toxicity against the
parasites. When epimastigotes were submitted to the treatment with piperine,
they showed significant morphologic alterations in the length of the cellular
body and flagellum when compared with the control. Treatment of the parasites
with intermediate concentrations of the drug interfered with the parasite’s
citokinesis, promoting the accumulation of cells with 2 nucleus and 2
kinetoplastes but not completely duplicated. Preliminary results have
demonstrated that piperine and some derivates were able to inhibit, in a dose
dependent way, malate dehydrogenase and glucose 6-phosphate dehydrogenase,
respectively NAD+ and NADP+ dependent enzymes. These data suggest that
one of the possible mechanisms of action of piperine is the perturbation of the
oxido-reductive balance through a generalized inhibition of dehydrogenases
that affects the entire energy metabolism of the parasite.
Supported by: CNPq, FAPERJ, TWAS and IFS.
QT21 - SYNERGISM BETWEEN STEROL BIOSYNTHESIS
INHIBITOR WITH THE CURRENT TREATMENT FOR
HUMAN TOXOPLASMOSIS
Dantas-Leite L1, Urbina J2, De Souza W1, and Vommaro R1
1Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos
Chagas Filho, CCS Universidade Federal do Rio de Janeiro, CCS, 21949-9000
- Rio de Janeiro – RJ, Brazil, and2Laboratório de Química Biológica, Centro de
Biofísica y Bioquímica, Instituto Venezolano de Investigaciones Científicas,
Apartado 21827, Caracas 1020A, Venezuela
Toxoplasma gondii is responsible for chronically infecting approximately
30% of the global human population (1), causing congenital disease, including
ocular demages in infants worldwide and is involved in fatal encephalitis in
immunocompromised individuals. In human toxoplasmosis, pyrimethamine
associated with other folate inhibitors such as sulfadiazine is the most usual
treatment, with high efficacy in toxoplasmic encephalitis and chorioretinitis
(2). However, this combination is associated with frequent and severe adverse
reactions, such as hematologic toxicity due to pyrimethamine and cutaneous
rash, leukopenia and thrombocitopenia due to the sulfonamide (3). The
antiproliferative effects of these folate inhibitors were potentiated by the
simultaneous incubation of tachyzoites of the RH strain with the inhibitor of
D24(25) sterol methyltransferase, 22,26-azasterol, as indicated by concave
isobolograms and fractional inhibitory concentrations. Monolayers of the
epithelial cell LLCMK2 in a 24-well plate were allowed to interact with
tachyzoites for 6 hours before the addition of the drugs. After the incubation
with the drugs, coverslips were fixed in Bouin’s fixative stained with Giemsa
and observed in a light microscope. The percentage of infected cells and the
parasite proliferation index were determined by examination of at least 400
cells of two different coverslips. Our results using pyrimethamine (0,1mg/ml)
and sulphadiazine (25mg/ml) in infected cells for 24 hours of treatment were
quite similar to those previously reported (4 and 5) reaching an inhibitory rate
of 74% of parasite proliferation. The association of the same concentration of
these drugs with 10mM 22,26-azasterol for 24 hours resulted in complete growth
arrest of T. gondii tachyzoites. Reducing the concentration of folate inhibitors
in ten times in combination with 10mM of azasterol produced 80% of inhibition
of parasite proliferation, indicating a synergistic effect. The ultrastructural
analysis of this material reveled dramatically cytotoxic effect on parasites
mitochondria and endodiogeny process.
Financial Support: CAPES, CNPq, FAPERJ and European Commission.
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QT22 - THERAPEUTIC ACTION OF ATP ON CUTANEOUS
LEISHMANIASIS
Chaves, S.P.; Torres-Santos, E.C.; Rossi-Bergmann, B. and Coutinho-Silva, R.
Instituto de Biofísica Carlos Chagas Filho - UFRJ
The current available therapy of leishmaniasis is painful and presents severe
side effects. In this context, our group has been studying the action of ATP in
infection. Since the ATP receptor P2X7 is highly expressed on macrophages,
and its activation leads to pore formation on the cell membrane, we explored
the possibility that P2X7 could be used to favour drug entrance. Peritoneal
macrophages were infected and cultured for 48 hours. The cells then were treated
with ATP (0, 500, 1000, 2000 and 4000 mM) plus Lucifer Yellow dye, for 10
min at 37ºC, and read at fluorimeter. The infection itself increased cellular
permeability, but in presence of ATP, permeabilization was much more notable,
sugesting that L. amazonensis infection increased P2X7 receptor expression in
vitro. In vivo, infected BALB/C mice were treated for three weeks, two times a
week, with PBS (20 ml), Glucantime (3mg in 20ml), Glucantime (3 mg) plus
ATP (50 mM, association volume 20 ml), and ATP (20ml at 50 mM) in the foot
lesions. The analysis of parasite load showed that ATP did not increase the
therapeutic effect of Glucantime, but showed itself an important anti-leishmanial
action, reducing the numbers of parasites by 65% (ATP alone), and 71% (ATP
plus Glucantime) in relation to PBS controls. To indirectly evaluation of P2X7
expression in vivo, infected and uninfected feet were cut off and homogenized
in PBS using a tissue grinder. The homogenate was treated with ATP (500mM
and 5mM) plus Topro 3 dye, and analyzed by FACS. These preliminary results
suggest that the therapeutic effect of ATP in vivo may be associated with the
increased cell permeability and that ATP may serve as a good adjuvant for the
treatment of leishmaniasis.
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QT23 - SYNTHESIS OF NOVEL QUINOLINE DERIVATIVES
WITH A POTENTIAL ANTILEISHMANIAL ACTIVITY
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Visceral leishmaniasis (VL) is a severe disease associated with infection of
the reticuloendothelial system by Leishmania species. Recent large scale
epidemics of VL in east Africa, India and in a small proportion, in Brazil, and
the emergence of a HIV epidemic make VL a priority for the World Health
Organization. Pentavalent antimonials have been cornerstone of treatment for
the last six decades, but antimonial-resistance strains have been reported. Within
the past five years, miltefosine has been demonstrated as the first effective and
safe oral treatment against VL, but besides the teratogenic effects, the price of
miltefosine is yet to be determined. Based in these circunstances, the development
of new drugs is imperious.
In this report, we studied the in vitro activity of four novel synthetized
quinoline compounds against L. (L.) chagasi promastigotes and intracellular
amastigotes, and determined the in vitro toxicity against mammalian cells by
the MTT assay. The 50% Effective Concentration (EC50) showed that compound
HGV02 was the most effective against promastigotes, with an EC50 value of
0.10 mg/mL. Compunds HGV01, HGV03 and HGV04, showed intermediate
values of 5.66 mg/mL, 7.48 mg/mL and 4.87 mg/mL, respectively. Pentamidine
was used as standard drug and showed an EC50 of 1.15 mg/mL. The intracellular
amastigote assay by using compounds at 10 mg/mL, showed lack of
antileishmanial activity for compounds HGV 01, HGV 03, HGV 04, but
compound HGV02 reduced more than 99% the parasite burden of the infected
macrophages. Glucantime was used as control and showed 100% reduction in
parasite burden. All compounds demonstrated citotoxicity for peritoneal
macrophages, despite of the high Selectivity Index (toxicity for mammalian
cells/EC50 in promastigotes) of 314 obtained with HGV02. These results
confirmed the potential antileishmanial activity of these novel quinoline
derivatives, and allow the use of these molecules as models for the design of
new synthetic compounds.
This work was supported by FAPESP (Proj. 99/08491-4) and LIMHCFMUSP-
49.
QT24 - LETHAL EFFECT OF NEW DERIVED-
NAPTHOQUINONE DRUGS AGAINST CRITHIDIA AND
HERPETOMONAS.
Souza CF1, Miranda MD1, Santos DO, Neto MN2, Gomes TS2 Ferreira VF2 &
*Bourguignon SC1
1Detpo de Biologia Celular e Molecular Instituto de Biologia, UFF; 2Depto de
Química Orgânica, Instituto de Química, UFF. *e-mail:saulo@vm.uff.br
Flagellate protozoa of the Trypanosomatidae family, which includes agents
of important parasitic diseases such as leishmaniosis and Chagas’ disease, infect
a wide range of hosts including animals and plants(Vickerman, 1994).
Trypanosomatids belonging to the Herpetomonas genus are commonly found
in the digestive tract of houseflies and blowflies, usually under the elongated
promastigote and opisthomastigote forms. Monoxenous trypanosomatids are
usually found in insect hosts and are considered to be not capable to cause
parasitic diseases in vertebrates (Wallace, 1966). However, recent data suggested
that monoxenous trypanosomatids could be implicated in human infections
(Jimenez et al.,1996, Pacheco et al. 1998, Silva JS et al, 2001). This way, we
decided to study the effect of new drugs against these trypanosomatids. The
biological activities of the naphthoquinones and derivatives a and β-lapachone,
extracted from trees of the genus Tabebuia, have been greatly studied. The
diversity of microbicidal effects, the easily to achieve the quinones in Brazilian
forest and the synthetic alternative pathway of obtaining it, led us to consider a-
lapachol and β-lapachone as starting points for chemotherapy studies. In the
present study, we display the effect of the new semi synthetic substances,
napthoquinone derivatives, on Crithidia and Herpetomonas. Materials and
Methods 1- Parasite- Crithida fasciculate (CI-IOC-048) and Herpetomonas
samuelpessoai (CI-IOC-067) were obtained from Dr. M. Auxiliadora Sousa
(Trypanosomatids Collection IOC, RJ Brazil) and were kept in liver infusion
tryptose (LIT) or BHI-medium. 2-Trypanocidal Assay and substances- A stock
solution of substance - α-lapachone (α-lap), β-lapachone (β-lap), Diazo of β-
lapachone (6-diazo-β-lap), epoxide of nor-α-lapachone, fenilidrazone-β-
lapachone, etil-furano-nor-β-lapachone, lapachol, LAPAc2O (lapachol acetate),
bacetone and epoxide of lawsone - was prepared in dimethyl sulfoxide (DMSO),
with the final concentration in the experiments of the 0.1%. 3-Analyze of the
drugs effect was done after quantification of active parasites on the 1st till the 7th
day of the culturing, by counting in a optical microscopy (Olympus BX41). The
final concentration of all the drugs tested was 50mM (group control was treated
with DMSO 0.1%). Results- The substances α-lap, 6-diazo-β-lap, epoxide of
nor-α-lap, 6-fenilidrazone-β-lapachone, etil-furano-nor-β-lapachone, lapachol
and bacetone partially inhibited the growth of both, C. fasciculate and H.
samuelpessoai, parasites. However, the substances Alil nor-b-lapachone and
epoxilau, were lethal these parasites. These substances were able to kill the
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parasites in a period of 72 hours. Here, we are showing the trypanosomicidal
potencial of these drugs on the different kinds of monoxenous trypanosomatids.
Supported by UFF/ FAPERJ.
QT25 - EFFECTS OF SYNTHETIC PEPTIDETEMPORIN A ON
TRYPANOSOMA CRUZI EPIMASTIGOTES FORMS
Souza, ALA.; Amado, DS.; Guedes, HLM.; Neves Jr, I. and Giovanni De -
Simone.S.*
Departamento de Bioquímica e Biologia Molecular, IOC, Rio de Janeiro, RJ
Brasil; Depart. de Biologia Celular e Molecular, Instituto de Biologia, UFF,
Niterói.
Antimicrobial peptides have been found in animal (vertebrate and invertebrate)
and plants kingdom but most of the reports have focused on bacterial than
eukariotics cells. They have a considerable structural diversity and consequente
aminoacid heterogeneity. Many of them present a potential terapeutic application
while others may be useful tools to probe and define important structural function
of proteins segments. In this work, flow cytometry, MTT activity and parasites
mobility were used to study the effect of one Synthetic peptide from Rana
temporaria skin (Temporin A) on T. Cruzi epimastigotes Cells forms. For flow
cytometry, T. cruzi epimastigotes forms were grown for 2h with different
concentrations of Temporin A (1mM - 1000mM) and after washing ethidium
bromide and fluorescein diacetate were addedies and the optical density measured
at 600nm and 410nm. T. cruzi epimastigote mixture cells containg 700mM/107cells
of the Temporin A presented 100% uptake of the dyes. These results with the low
activity of the mitochondrial desigenasys MTT mensured demonstrated that the
T. cruzi membranes is a target for lysis induced pore formation. The analysis of
other antimicrobial peptides from natural sure is in progress.
Supported by FIOCRUZ and CNPq
QT26 - PROTEASOME AS TARGET OF ANTIMALARIAL DRUGS
Goulart, H. R., Balanco J.M.F., Peres V.J., Katzin A.M and Kimura E.A.
Departamento de Parasitologia, ICB, USP, Brasil. e-mail: herbertg@usp.br
The development of new antimalarial drugs is an urgent priority considering
the increasing prevalence of drug-resistant Plasmodium falciparum parasites
and the absence of effective vaccines or vector control measures. The existence
of a Plasmodium proteasome has been shown indirectly by using inhibitors.
Lactacystin inhibits the in vitro development of erythrocytic stages of P.
falciparum and its inhibitory effect is cell cycle stage-especific and, despite the
low therapeutic index of lactacystin that reduced parasitemia in rats, the parasite
proteasome remains as a prominsing candidate drug target. Lactacystin was found
to inhibit the growth of three different lines of P. falciparum at similar molar
concentrations, and was consistently more effective against chloroquine-resistent
than chloroquine-sensitive-parasite (Li et al., 2000, International Journal for
Parasitology 30, 729-733). A gene encondig a 20S proteasome b-subunit has
been cloned in P. falciparum. During erythrocytic stages the parasite undergoes
radical morphological changes and many rounds of replication, events that likely
require proteasome activity. Proteasomes are major components of the eukaryotic
cellular machinery mediating the normal turnover of proteins and the degradation
of proteins that have been improperly folded or denatured (Gantt et al., 1998,
Antimicrobial Agents Chemotherapy 42, 2731-2738). In our laboratory,
preliminary results demonstrated that proteasome activity was presented in
schizont stage, suggesting that activity is probably relationated with erythrocytic
schizogony where occurs highest turnover of proteins and nucleic acid synthesis.
We are testing the limonene, nerolidol and lovastatin in cultures of P. falciparum
(isolated NF 54, clone 3 D7). The values of IC50 were: a) nerolidol 760 nM, b)
limonene 1,22 mM and c) lovastatin 50 mM. In studies reported in the laboratory
have been observated that nerolidol could be interfering in the elongation
involved in the biosynthesis of the isoprenic chain attached to benzoquinone
ring of coenzyme Q (Macedo et al., 2002, FEMS Microbiology Letters 207, 13-
20) and, limonene arrested parasite development and inhibits isoprenylation of
proteins in P. falciparum (Moura et al., 2001, Antimicrobial Agents
Chemotherapy 45, 2553-2558). Therefore, we will study how inhibition of
isoprenylation of proteins and interference in the elongation of the isoprenic
chain attached to benzoquinone ring of coenzyme Q in cultures of the P.
falciparum could be interfering in the proteasome activity. In human cancer,
pro-drug form of lovastatin have been demonstrated to inhibit the proteasome
activity (Sharmila Rao et al.,1999, Biochemistry 96, 7797-7802) suggesting
that lovastatin could be inhibiting this activity in P. falciparum.
This research is sponsored by: FAPESP, CNPq, PRONEX, UNDP/World Bank/
WHO
QT27 - ORAL DELIVERY OF MEGLUMINE ANTIMONIATE
USING β-CYCLODEXTRIN FOR THE TREATMENT OF
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The need for daily parenteral administration represents one of the most serious
limitations in the clinical use of pentavalent antimonials against leishmaniasis. In
this work, we investigated the ability of β-cyclodextrin (CD) to enhance the oral
absorption of antimony and to promote the oral efficacy of meglumine antimoniate
(MA) against experimental cutaneous leishmaniasis. The occurrence of interactions
between CD and MA was demonstrated through the changes induced in the spin-
lattice relaxation times of both MA and CD protons. When MA was given orally
to Swiss mice in either free or CD-complexed forms, antimony plasma levels after
MA/CD were found to be about three times higher than after free MA. Anti-
leishmanial efficacy was evaluated in BALB/c mice experimentally infected with
Leishmania (L.) amazonensis. Animals daily treated with oral MA/CD (32 mg
Sb/Kg) developed significantly smaller lesions when compared to animals treated
with MA (120 mg Sb/Kg) and control animals (treated with saline). The
effectiveness of oral MA/CD was equivalent to that of MA given intraperitoneally
at a 2-fold higher antimony dose. The anti-leishmanial efficacy of MA/CD was
confirmed by the significantly lower parasite load in the lesions of treated animals,
when compared to saline controls. This work reports for the first time the
effectiveness of an oral formulation for pentavalent antimonials.
This work was supported by grants from CNPq (521010/97-7 and Brazilian
Nanobiotechnology Network), CAPES and FAPEMIG.
QT28 - TARGETING LEISHMANIA (L.) CHAGASI
AMASTIGOTES INTO MACROPHAGES: THE USE OF
DRUGS ENTRAPPED INTO LIPOSOMES CONTAINING
PHOSPHATIDYLSERINE
André Gustavo Tempone1, Daniel Perez Vieira2, Susanne Rath3, Renato A.
Mortara4 and Heitor Franco de Andrade Jr.2
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Macrophages, the target cells in the therapy of Leishmaniasis, express a
range of surface glycoproteins, named scavenger receptors, able to bind different
classes of molecules, including phosphatidylserine, a negatively charged lipid
that could be easily included in liposomal formulations, increasing the targeting
ability of drugs. In this study, we devised liposome-entrapped antimony (Sb-
LP) with the negatively charged lipid phosphatidylserine, in order to improve
their targeting to infected macrophages.
By determining the 50% Effective Concentration in Leishmania (L.) chagasi-
infected macrophages, Sb-LP was 16-fold more effective (EC50 = 14.11 mM)
than the free drug (EC50 = 225.9 mM). Confocal microscopy analysis showed
the delivery of DIL-labeled PS-liposomes and ethidium bromide-labeled PS-
liposomes to the L. (L.) chagasi parasitophorous vacuole (PV), suggesting that
fusion between the PV and the liposomal formulation migth have occured, since
intracellular amastigotes appeared fluorescent after shorth time incubation.
Experimental studies, using BALB/c mice infected with L. chagasi amastigotes,
showed that pentavalent antimony entrapped into PS-liposomes was at least
133-fold more effective than free antimony, since 100% reduction in the liver
parasite burden was only achieved with 100 mg SbV/Kg using free drug,
compared to 0,75 mg SbV/Kg by using the PS-liposome entrapped antimony.
These results suggest that PS-liposomes could improve the efficacy of old drugs,
such as pentavalent antimony, via targeted delivery to Leishmania-infected cells.
This work was supported by FAPESP (Proj. 99/08491-4) and LIMHCFMUSP-49.
QT29 - NATURAL ALTERATION IN THE SUSCEPTIBILITY/
RESISTANCE PATTERN TO BENZNIDAZOLE IN
TRYPANOSOMA CRUZI POPULATIONS MAINTAINED IN
ACUTE OR LONG TERM CHRONIC INFECTIONS IN MICE
OR DOGS
Caldas S, Santos FM, Cáu SBA, Caldas IS, Veloso VM, Lana M, Tafuri WL,
Bahia MT
Núcleo de Pesquisa em Ciências Biológicas – UFOP
The susceptibility to drugs used in etiologic treatment of Chagas disease is
defined by the genetic characteristics of T. cruzi strains (Toledo et al., AAC
47:223, 2003). However, some reports have been published concerning the in
vivo induction to drug resistance by pressure of the benznidazole (Bz) in T.
cruzi strain with partially resistance to this drug (Murta et al., Parasitology
116:165, 1998). On the other hand, the natural induction of resistance to Bz in
T. cruzi populations during the long term chronic phase in dogs was demonstrated
recently by Veloso et al., Mem Inst Oswaldo Cruz, 96:1005, 2001.
In this study new T. cruzi populations of dogs with chronic Chagas disease
(2 to 10 years) were isolated. These dogs were previously inoculated with the
Berenice-62 and Berenice-78 parental T. cruzi strains, that presented 100% of
susceptibility to Bz. After isolation, all T. cruzi populations that showed resistance
to Bz were maintained in Swiss outbreed mice, through successive cycles of
treatment (SCT) with Bz. Mice were treated with oral doses of 100 mg of Bz/
kg, for 20 consecutive days. Animals were considered cured when parasitological
(fresh blood examination, hemoculture), molecular (PCR), and serological tests
were negative. After treatment the animals were submitted to immunosuppressive
therapy with cyclophosphamide. After reactivation of infection the
trypomastigotes were inoculated in mice that were treated again. These SCT
were repeated in order observe the stability of Bz resistance/susceptibility
phenotype. In this study five T. cruzi populations (Be-62 A and B, Be-78 C, D
and E) isolated of dogs infected with Be-78 and Be-62 T. cruzi parental strains
were evaluated. In general, the parasites maintained in treated mice through of
SCT showed an altered Bz-resistance: (1) 0% in 1o SCT for Be-62A; (2) 20%
(1o SCT) to 100% after the 5o SCT for Be-62B (3) 90% (1o SCT) to 100% in 3o
CST, with maintenance of 100% of Bz-resistance until the13o SCT for Be-78C;
(4) 90% (1o SCT) to 100% in 6o SCT for Be-78D; (5) 80% (1o SCT) to 14,3% in
4o SCT for Be 78E;. All animals inoculated with Be-78C showed natural
reactivation of the parasitemia post-treatment after the 9o treatment cycle.
In this work we demonstrate that T. cruzi populations isolated with dogs
inoculated with the same T. cruzi parental strain present different Bz resistance
levels. Besides, the maintenance of these T. cruzi populations in successive blood
passages in treated mice altered in several ways the Bz resistance level,
exemplified by the greater Bz resistance observed in Be-78C and for the decrease
of the Bz resistance during the SCT in Be-78E.
Financial support: UFOP, FAPEMIG
QT30 - NATURAL ALTERATION IN THE SUSCEPTIBILITY/
RESISTANCE PATTERN TO BENZNIDAZOL IN
TRYPANOSOMA CRUZI POPULATIONS MAINTAINED IN
ACUTE OR LONG TERM CHRONIC INFECTIONS IN MICE
OR DOGS.
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Bahia ML
Núcleo de Pesquisa em Ciências Biológicas, UFOP
Natural induction of resistance to Benznidazol (Bz), in T. cruzi populations,
during the chronic infection of dogs was demonstrated previously by Veloso et
al. (Mem Inst Oswaldo Cruz, 96:1005, 2001).
In this work new T. cruzi populations were isolated from dogs with chronic
infections (inoculated with Bz-susceptible strains), and susceptibility to Bz was
determined after the isolation and during the maintenance these populations
through successive blood passages in mice (SBP). Swiss outbreed mice were
infected by intraperitoneal route with the Berenice-62 A and B and Berenice-78
C, D, E isolated from different dogs after 2 to 10 years of infection with Be-62
and Be-78 parental T. cruzi strains, respectively. The Bz susceptibility was
determined in the first blood passage in mice, and to follow the T. cruzi
populations were maintained in SBP (in the absence of specific treatment).
Sixteen mice were inoculated at each five SBP for the evaluation of the infectivity,
parasitaemia curves, mortality and susceptibility to Bz. The parasitological cure
was determined by fresh blood examination, hemoculture, serological test, PCR
and reactivation of the disease by immunosuppressive therapy with
cyclophosphamide. After only one blood passage in mice we observed 0%, 20%,
80%, 90% and 80% of resistance to Bz amongst the animals inoculated with
isolate Be-62 A and B and Be-78C, D, E respectively, showing a natural induction
of Bz resistance during long term chronic infection in dogs. On the other hand,
a new change in Bz-susceptibilities was found during the maintenance of the
parasite in BSP (acute phase). Diverse variation patterns were observed such as:
(1) stability in the Bz resistance in Be-62 A (0 to 20% in 10 SBP), Be-62 B (20
to 40% in 15 SBP) and Be-78 C (80 to 100% in 55 SBP); (2) reduction in the Bz
resistance in Be-78 D (90 to 22% in 40 SBP), and Be-78 E (80 to 30% in 10
SBP). The alteration of the Bz resistance degree during the SBP was not
accompanied by significant variation in other biological parameters such as the
parasitaemia curves pattern, infectivity and mortality
These results are in agreement with the hypothesis that the maintenance
form of the T. cruzi (long term chronic infections or in successive blood passages
-acute phase), can influence the susceptibility/resistance phenotype of
benznidazole in the T. cruzi populations studied.
Financial support: UFOP, FAPEMIG, PIBIC-CNPq
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QT31 - EVALUATION OF BENZNIDAZOLE TREATMENT IN
MIXED INFECTIONS OF BALB/C MICE WITH CLONES OF
TRYPANOSOMA CRUZI FROM DIFFERENT GENOTYPES.
Martins HR1; Bandeira LC1; Delaqua FA3; Oliveira MR1; Souza, RM1; Caldas,
S1; Veloso, VM3; BahiaMT3; Carneiro CM2, Tafuri, WL2; Lana M1
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The use of biochemical and molecular markers is useful on the demonstration
of T. cruzi natural mixed infection in humans as well as vectors and reservoirs.
Mixed infections were experimentally demonstrated in vectors (Pinto et al,
Parasitol. Res. 84: 348, 1998) and mice (Lana et al, Exp. Parasitol, 96:61, 2000).
It was showed that there is not just a juxtaposition of the parasites of the mixture
suggesting a stimulation or inhibition from one clone to another, sometimes
reciprocal. The goal of this work is to characterize the mixed infection with
clones from different genotypes comparing their biological properties and
susceptibility to benznidazole with results provided from monoclonal infections
obtained for Toledo et al, AAC 47: 223 (2003). Until now the clones used into
the mixtures were: two clones from genotype 19, two from genotype 20 (T.
cruzi I) and two from genotype 39 (T. cruzi II) (Tybayrenc & Ayala, Evolution
42: 277, 1988), one more susceptible and other more resistant to BZ (Toledo e
cols, AAC 47:223, 2003).Groups with 16 BALB/c mice were inoculated via IP,
with 5000 blood trypomastigotes of each clone. After the pre-patent period, 8
animals were treated during the acute phase by oral doses of 100mg/kg weight
for 20 consecutives days and evaluated in parallel with 8 not treated control
mice. The mortality rates were daily registered until the 120o day and the
hemoculture performed 30 days post treatment.
Preliminary results indicate that the infectivity was always 100%, similar
or higher than the observed in monoclonal infections when compared with the
most infective one. The mortality rates are similar to the observed in monoclonal
infections. The analysis of parasitemia showed an apparent stimulator effect
between the clones (6/9 = 66% from the experiments) suggesting more than a
juxtaposition of individual clones, since the parasitemia level were higher than
the theoretical media from the mixture (arithmetic media from monoclonal
infections). Only one experiment (Gambacl1 + Cuicacl1), showed parasitemia
lower than the theoretical mixture, which suggest an inhibitory effect between
the clones. The chemotherapic treatment strongly reduced the parasitemia of all
mixtures that remained subpatent after the beginning of the treatment. These
results corroborate data of monoclonal infections. However in some cases the
reactivation of parasitemia was observed after the end of treatment although
with lower level in relation to the control group. The results of hemoculture
showed that mixtures with clones partially susceptible to BZ (Gamba + SO3cl5)
were 100% positive indicating the permanency of the infection in all animals.
Serological results (ELISA and anti-trypomastigotes antibodies –AATV by Flow-
Citometry) and PCR that will be used as criterion of cure were not evaluated
yet.
Grants: FAPEMIG, CNPq, CAPES e UFOP.
QT31 - BENZNIDAZOLE TREATMENT FOLLOWING ACUTE
TRYPANOSOMA CRUZI INFECTION TRIGGERS CD8+ T
CELL EXPANSION AND PROMOTES RESISTANCE TO
REINFECTION
Olivieri, B.P, De Souza, A.P., Cotta-de-Almeida, V. & Araújo-Jorge, T.C.
Lab. de Biologia Celular, DUBC, Instituto Oswaldo Cruz, FIOCRUZ, 21045-
900, Rio de Janeiro, Brasil. E-mail address: olivieri@ioc.fiocruz.br
Many studies have shed light on the mechanisms underlying both
immunoprotection and immune dysregulations arising after Trypanosoma cruzi
infection. However, little is known about the impact of benznidazole (N-benzyl-
2-nitroimidazole acetamide), the available drug for the clinical treatment in
Brazil, upon the immune response in the infected host. Here we investigate the
effect of benznidazole therapy on the lymphoid compartment during the course
of experimental T. cruzi-infection. Although amelioration of a variety of clinical
and parasitological signs was observed in treated mice, recovery from splenocyte
expansion was not detected. Interestingly, this sustained splenomegaly observed
in benznidazole-treated mice was due to a preferential expansion of CD8+ T
lymphocytes. Moreover, although blocking the expansion of recently activated
CD4+ and CD8+ T cells seen in infected hosts, benznidazole treatment led to a
selective expansion of effector/memory CD8+ T lymphocytes, associated with
lower rate of apoptosis. Besides, surviving benznidazole-treated infected animals
were protected from death after reinfection, performed in late phases after the
primary infection. Together, these data suggest that, in addition to its well-known
direct role in blocking parasite replication in vivo, benznidazole appears to
directly affect immune regulation in T. cruzi infected hosts.
Supported by CAPES, IOC and CNPq
QT33 - TARGET ORGANELLES OF BETA-LAPACHONE
DERIVATIVES IN TRYPANOSOMA CRUZI
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Plants containing naphtoquinones are commonly employed in folk medicine
and studies about the anti-tumoral activity of beta-lapachone, inducing apoptosis
[1-2] and inhibiting topoisomerases, led to the suggestion of it potential use in
the clinics as adjuvant for treatment of certain types of cancer [3]. The effect of
this quinone against Trypanosoma cruzi is associated to free radicals generation
[4]. Naphthoquinones derivatives, isolated from Tabebuia (“ipês”), and semi-
synthetic derivatives totalizing 60 compounds have been assayed against
trypomastigotes of T. cruzi, and three with the highest activity against were
naphthoimidazoles derived from beta-lapachone, with the aromatic moieties
phenyl (N1), 3-indolyl (N2) and para-phenyl (N3) linked to the imidazole ring
[5-7].
In the present work, we observed effect of these three derivatives against
amastigotes of T. cruzi interiorised in peritoneal macrophages and heart muscle
cells primary cultures, and host cell damage occurred only at concentrations
about 20-fold higher than those needed to block intracellular parasite
proliferation.
Flow cytometry and ultrastructural studies of epimastigotes and
trypomastigotes treated with N1, N2 or N3, showed swelling of the mitochondrion
in both parasite forms. It were also observed disorganization of the reservosome
morphology in epimastigotes, and damage of the kinetoplast in trypomastigotes.
The mitochondrion alterations were associated with decrease of the membrane
potential of this organelle, in relation to untreated parasites, detected by
rhodamine 123 [8], despite the maintenance of the integrity of the plasma
membrane monitored by propidium iodide [9]. Experiments using acridine orange
as marker of acidic compartments, such as reservosomes and acidocalcisomes
in epimastigotes [10], and acidocalcisomes in trypomastigotes [11] showed a
decrease in fluorescence in treated parasites.
Taken together, these data suggest that the mitochondrion and acidic
compartments are the first targets of the action of naphthoimidazoles against T.
cruzi. The potent activity of the naphthoimidazoles on intracellular amastigotes
and bloodstream trypomastigotes together with their low cytotoxicity to the
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mammalian cells encourage us to performed in vivo experiments with this
derivatives of beta-lapachone.
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Chagas’ disease, caused by the parasite Trypanosoma cruzi, is endemic in
Latin America. It is a very serious public health problem in several countries,
with about 17 million people known to be infected with the parasite, and a
further 100 million at risk of infection, either through contact with an insect
vector or via blood transfusion. At present, the only available therapeutic agent
for Chagas’ disease in Latin America is benzanidazole. In this context, an
intensive research program has been focused on the search for alternative natural
and synthetic drugs. The biological activities of the naphthoquinones and
derivatives a and β-lapachone, extracted from trees of the genus Tabebuia, have
been intensively studied. The diversity of microbicidal effects, the easy access
to natural sources of these quinones in Brazilian rain forest and the synthetic
alternative routes led us to consider α-lapachol and β-lapachone as starting points
for chemotherapy studies. In the present work we describe the effect of the new
semi synthetic substances, napthoquinone derivatives, on epimastigote form of
T. cruzi. Materials and Methods 1- Parasite- T. cruzi Dm28c epimastigotes was
raised in liver infusion tryptose (LIT) or BHI-medium. 2-Trypanocidal Assay
and substances- A stock solution of substance - α-lapachone (α-lap), β-lapachone
(β-lap), Diazo of β-lapachone, epoxide of nor-α-lapachone, fenilidrazone, Alil
nor-β-lapachone, lapachol, lapachol with zinc and acetic anidrid, bacetone and
epoxide of lawsone - was prepared in dimethyl sulfoxide (DMSO), with the
final concentration in the experiments of the 0.1%. 3-Analyze of the drugs action-
was realized by number of active (alive) parasites on the 1st, 2nd, 3rd, 4th, 5th and
7th days of the culture, using a Neubauer chamber. The final concentration of all
drugs was 50mM. and the group control was treated with DMSO 0.1%. Results-
The substances α-lap, diazo of β-lap, epoxide of nor-α-lap, fenilidrazone, alil
nor-β-lapachone, lapachol and bacetone inhibited the growth partially but they
were not lethal for T. cruzi. However, the substances β-lap, alil nor-β-lapachone
and epoxilau, were lethal for T. cruzi. These substances killed the parasites in a
period of 72 hours. These results revealed these substances to have good
trypanosomicidal activities.
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Chagas’ disease, caused by the parasite Trypanosoma cruzi, is endemic in
Latin America. It is a very serious public health problem in several countries,
with about 17 million people known to be infected with the parasite, and a
further 100 million at risk of infection, either through contact with an insect
vector or via blood transfusion. At present, the only available therapeutic agent
for Chagas’ disease in Latin America is benzanidazole. In this context, an
intensive research program has been focused on the search for alternative natural
and synthetic drugs. The biological activities of the naphthoquinones and
derivatives a and β-lapachone, extracted from trees of the genus Tabebuia, have
been intensively studied. The diversity of microbicidal effects, the easy access
to natural sources of these quinones in Brazilian rain forest and the synthetic
alternative routes led us to consider lapachol and β-lapachone as starting points
for chemotherapy studies. In the present work we describe the effect of the new
semi synthetic substances, napthoquinone derivatives, on epimastigote form of
T. cruzi. Materials and Methods 1- Parasite- T. cruzi Dm28c epimastigotes was
raised in liver infusion tryptose (LIT) or BHI-medium. 2-Trypanocidal Assay
and substances- A stock solution of substance - α-lapachone (α-lap), β-lapachone
(b-lap), Diazo of β-lapachone (6-diazo-β-lap), epoxide of nor-α-lapachone,
fenilidrazone-β-lapachone, etil-furano-nor-β-lapachone, lapachol, LAPAc2O
(lapachol acetate), bacetone and epoxide of lawsone - was prepared in dimethyl
sulfoxide (DMSO), with the final concentration in the experiments of the 0.1%.
3-Analyze of the drugs action- was realized by number of active (alive) parasites
on the 1st, 2nd, 3rd, 4th, 5th and 7th days of the culture, using a Neubauer chamber.
The final concentration of all drugs was 50mM. and the group control was treated
with DMSO 0.1%. Results- The substances α-lap, 6-diazo-β-lap, epoxide of
nor-α-lap, 6-fenilidrazone-β-lapachone, etil-furano-nor-β-lapachone, lapachol
and bacetone inhibited the growth partially but they were not lethal for T.cruzi.
However, the substances β-lap, etil-furano-nor-β-lapachone and epoxilau, were
lethal for T.cruzi. These substances killed the parasites in a period of 72 hours.
These results revealed these substances to have good trypanosomicidal activities.
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QT36 - A NEW SYNTHETIC CHALCONE WITH INCREASED
ACTIVITY AND SELECTIVITY AGAINST MURINE
CUTANEOUS LEISHMANIASIS.
Falcão, C. A. B.; Torres-Santos, E. C.; Yunes, R and Rossi-Bergmann, B.
We showed previously the therapeutic effectiveness of the chalcone 2’-6’-
dihydroxy-4’-methoxychalcone (DMC), isolated from the plant Piper aduncum
against murine leishmaniasis (Antim. Ag. Chemot. 43:1234-41,1999). Nineteen
analogous were synthesized adding different substitute groups on the original
plant molecule to optimize its efficiency. The chalcones were incubated at
differents concentrations with fluorescent promastigotes and intracellular
amastigotes of Leishmania (L.) amazonensis-GFP. The leishmanicidal activity
was expressed as fluorescent intensity of the samples. For cytotoxic activity
against mammalian cells, the mouse lymphocytes were incubated for 48 hours
with different concentrations of the chalcones in the presence of 2.5 mg/ml Con
A with and inhibition of cell proliferation measured by incorporation of 3H-
thymidine in the last 6 hours. Alternatively, mouse macrophages were incubated
for 48 hours with the chalcones and cell viability measured by incorporation of
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propidium iodide. Four chalcones exhibited high leishmanicidal activity and
low citotoxicity to mammalian cells. Presence of Cl and Br, as well as the NO2
group increased the leishmanicidal activity of the original molecule. However,
Cl also increases the citotoxicity to lyphocytes and macrophages. Para
substitutions in the second ring drastically reduced its antileishmanicidal activity.
The NO2-containing CH8 chalcone was the most selectively active molecule,
and this was selected for in vivo assays. BALB/c mice were infected with 2x106
promastigotes of fluorescent Leishmania (L.) amazonensis in the ear and afer 7
days treated s.c. in the lesion with CH8 (3,3 mg) or Pentostan (200 mg) in a
volume of 10 ml of saline, twice a week, for four weeks. The CH8 chalcone-
treated animals developed significantly smaller lesions as compared with saline
controls. The parasite burden was also effectively controlled, and was as low as
obtained in animals treated with much higher Pentostan doses.
These resullts show that structure/activity analysis of the synthetic chalcones
led to a potential lead compound (CH8) with in vitro and in vivo antileishmanial
selective activity.
QT37 - EFFECT OF THE ANTIMALARIAL DRUGS
QUINIDINE AND CLOTRIMAZOLE ON HEMOZOIN
FORMATION IN THE BLOOD FEEDING INSECT RHODNIUS
PROLIXUS
Corrêa Soares, J.B.L., Oliveira, M.F., Oliveira, P.L.
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Brasil. e-mail: jbcorrea@bioqmed.ufrj.br
The blood-feeding organisms use hemoglobin as the major food source and
its digestion result in heme release. Free heme is a powerful generator of reactive
oxygen species which can damage a diversity of macromolecules. A diversity of
protective mechanisms have been described in order to avoid the toxic effects of
free heme. One of these mechanisms relies in the aggregation of heme into a
harmless crystal named hemozoin (Hz), in different hematophagous organisms
such as Plasmodium, Schistosoma and the triatomine insect Rhodnius prolixus.
Quinoline-derived drugs, such as chloroquine, form complexes with heme blocking
Hz production in Plasmodium and in R. prolixus. In this present work, we
investigated the effects of inhibition of heme aggregation by two antimalarial
drugs, quinidine and clotrimazole, in Rhodnius prolixus midgut. When adult insects
were fed with different concentrations of quinidine, there was a dose-dependent
inhibition of Hz production in vivo. At 500 mM, quinidine inhibited Hz production
in more than 99% in the midgut. The azole derivative clotrimazole, also inhibited
Hz formation in vivo when insects were fed with 50mM of this drug. Moreover,
the inhibition of heme aggregation by quinidine results in a dose-dependent increase
of heme levels in the hemolymph. Furthermore, a slight reduction in protein content
in the hemolymph of quinidine fed insects, was observed. Taken together these
results suggest that heme detoxification into Hz is a target of the quinoline and
others antimalarial drugs and that this process has an important physiological role
to this insect.
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